Spots Global Cancer Trial Database for alk negative nsclc
Every month we try and update this database with for alk negative nsclc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver Mutations | NCT05157776 | NSCLC, Stage II... EGF-R Negative ... ALK Negative NS... | PD-1 and chemot... | 18 Years - 75 Years | Tongji University |